Literature DB >> 75191

Complement-mediated lysis of type-C virus: effect of primate and human sera on various retroviruses.

S A Sherwin, R E Benveniste, G J Todaro.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1978        PMID： 75191     DOI： 10.1002/ijc.2910210103

Source DB:  PubMed          Journal:  Int J Cancer        ISSN： 0020-7136            Impact factor:   7.396


× No keyword cloud information.
  16 in total

1.  Type C retrovirus inactivation by human complement is determined by both the viral genome and the producer cell.

Authors:  Y Takeuchi; F L Cosset; P J Lachmann; H Okada; R A Weiss; M K Collins
Journal:  J Virol       Date:  1994-12       Impact factor: 5.103

Review 2.  The complement system: its importance in the host response to viral infection.

Authors:  R L Hirsch
Journal:  Microbiol Rev       Date:  1982-03

3.  The resistance of retroviral vectors produced from human cells to serum inactivation in vivo and in vitro is primate species dependent.

Authors:  N J DePolo; C E Harkleroad; M Bodner; A T Watt; C G Anderson; J S Greengard; K K Murthy; T W Dubensky; D J Jolly
Journal:  J Virol       Date:  1999-08       Impact factor: 5.103

4.  Inhibitors of retrovirus infection are secreted by several hamster cell lines and are also present in hamster sera.

Authors:  D G Miller; A D Miller
Journal:  J Virol       Date:  1993-09       Impact factor: 5.103

5.  Effects of a heat-labile factor(s) in normal serum on the interferon-inducing activity of Newcastle disease virus (NDV). Brief report.

Authors:  F Taguchi; Y Nishimura
Journal:  Arch Virol       Date:  1983       Impact factor: 2.574

6.  In vitro activation of feline complement by feline leukemia virus.

Authors:  L Kobilinsky; W D Hardy; R Ellis; S S Witkin; N K Day
Journal:  Infect Immun       Date:  1980-07       Impact factor: 3.441

7.  Disintegration of retroviruses by chelating agents.

Authors:  V Wunderlich; G Sydow
Journal:  Arch Virol       Date:  1982       Impact factor: 2.574

8.  Virolysis of mouse mammary tumor virus by sera from breast cancer patients.

Authors:  S S Witkin; R A Egeli; N H Sarkar; R A Good; N K Day
Journal:  Proc Natl Acad Sci U S A       Date:  1979-06       Impact factor: 11.205

9.  Mouse immunoglobulin antibodies require complement for neutralization of mouse retroviruses.

Authors:  P S Sarma; W P Rowe
Journal:  J Virol       Date:  1983-03       Impact factor: 5.103

10.  Evaluation of the Galalpha1-3Gal epitope as a host modification factor eliciting natural humoral immunity to enveloped viruses.

Authors:  R M Welsh; C L O'Donnell; D J Reed; R P Rother
Journal:  J Virol       Date:  1998-06       Impact factor: 5.103
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.